| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Characterizing Absorption Properties of Dispersible Pretomanid Tablets Using Population Pharmacokinetic Modelling
|
Zou, Yuanxi
|
|
|
61 |
11 |
p. 1585-1593
|
article
|
| 2 |
Clinical Pharmacokinetics and Pharmacodynamics of Rucaparib
|
Liao, Mingxiang
|
|
|
61 |
11 |
p. 1477-1493
|
article
|
| 3 |
Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
|
Montanha, Maiara Camotti
|
|
|
61 |
11 |
p. 1641
|
article
|
| 4 |
Evaluation of Absorption and Metabolism-Based DDI Potential of Pexidartinib in Healthy Subjects
|
Zahir, Hamim
|
|
|
61 |
11 |
p. 1623-1639
|
article
|
| 5 |
Meropenem Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy
|
Thy, Michael
|
|
|
61 |
11 |
p. 1609-1621
|
article
|
| 6 |
Optimising the Nadroparin Dose for Thromboprophylaxis During Hemodialysis by Developing a Population Pharmacodynamic Model Using Anti-Xa Levels
|
Jaspers, Tessa C. C.
|
|
|
61 |
11 |
p. 1559-1569
|
article
|
| 7 |
Pharmacokinetic Study of Conjugated Equine Estrogens in Healthy Chinese Postmenopausal Women Using a Parallel Two-Column LC–MS/MS Method
|
Shi, Meiyun
|
|
|
61 |
11 |
p. 1571-1583
|
article
|
| 8 |
Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion
|
Nassar, Yomna M.
|
|
|
61 |
11 |
p. 1595-1607
|
article
|
| 9 |
Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect
|
Narendra, Gera
|
|
|
61 |
11 |
p. 1495-1517
|
article
|
| 10 |
Semi-mechanistic Modeling of Hypoxanthine, Xanthine, and Uric Acid Metabolism in Asphyxiated Neonates
|
Chu, Wan-Yu
|
|
|
61 |
11 |
p. 1545-1558
|
article
|
| 11 |
The Cytokine Release Syndrome and/or the Proinflammatory Cytokines as Underlying Mechanisms of Downregulation of Drug Metabolism and Drug Transport: A Systematic Review of the Clinical Pharmacokinetics of Victim Drugs of this Drug–Disease Interaction Under Different Clinical Conditions
|
Gatti, Milo
|
|
|
61 |
11 |
p. 1519-1544
|
article
|
Journal description